Valeritas, a developer of drug delivery solutions, has completed Series C round of financing of $150m to support commercialization of the V-Go Disposable Insulin Delivery Device.
The V-Go uses h-Patch technology and provides basal-bolus insulin therapy for adult patients with diabetes who require insulin.
The V-Go delivers a continuous preset basal rate of insulin and allows for on-demand bolus dosing at mealtimes, thereby providing an alternative to multiple daily insulin injections.
The V-Go is filled with insulin using a simple, disposable, point-of-care filling accessory – the V-Go EZ Fill.
Valeritas CEO Kristine Peterson said millions of adult patients suffer from Type 2 diabetes and require insulin, and they believe the V-Go will be an important treatment option to assist in the management of their diabetes.